NCT02502019View on ClinicalTrials.gov

HEMOBLAST Pilot Clinical Investigation

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Hemostasis
Interventions
DEVICE

HEMOBLAST Bellows

HEMOBLAST™ Bellows is intended for use in surgical procedures as an adjunct to hemostasis when control of bleeding by conventional procedures is ineffective or impractical.

Trial Locations (3)

Unknown

University of Southern California, Los Angeles

University of North Carolina at Chapel Hill, Chapel Hill

Danville Orthopedic Clinic, Danville

All Listed Sponsors
lead

Biom'Up France SAS

INDUSTRY

NCT02502019 - HEMOBLAST Pilot Clinical Investigation | Biotech Hunter | Biotech Hunter